Understanding factors associated with delay in seeking treatment among locally advanced and metastatic breast cancer in Hospital Raja Perempuan Zainab II
Loading...
Date
2020
Authors
Karim, Mohd Firdaus A.
Journal Title
Journal ISSN
Volume Title
Publisher
Pusat Pengajian Sains Kesihatan, Universiti Sains Malaysia
Abstract
Breast cancer is the second most cancer common detected in the world, as reported by
GLOBOCAN in 2012 and contribute about 25% of overall cancer worldwide.1 It is expected to
increase every year as a lot of promotion had been done to increase breast cancer awareness.
Despite the public awareness and education regarding breast cancer, patient with locally advanced
breast cancer or metastatic breast cancer is still commonly seen in our community.
In Kelantan, it had been reported by Cancer Registry 2006, up to 34.9% cases presented at
stage 4, comparing only 20.7% in stage 3 and 19% in stage 1.2 Breast cancer is a disease that have
good survival rate if detected early as delay in seeking treatment associated with larger tumor,
more advanced stage and subsequently poorer prospect of survival.
Breast cancer delay can be defined as more than 12 weeks between discovery of the symptom
by patient and the beginning of the definitive treatment. This can be further classified as patient
delay (waiting 3 months or more before seeking treatment) or health provider delay (one month or
more from first patient presentation till beginning of treatment). MA Richard et all had analyzed
2964 patient with different stage of breast cancer, shown that the survival after 10 years for patient
presented less than 12 weeks after first symptom was 52% and 47% for longer delays.3
According to The Clinical Practice Guidelines (CPG) on management of breast cancer in
Malaysia, it is recommended that breast cancer patient should receive primary treatment within 2
months of presenting symptom.4
The aim of this study is to understand the factors associated with delay in seeking treatment
for patient presented with locally advanced and metastatic breast cancer in HRPZ II.
Description
Keywords
breast cancer